BioPharma Credit (LON:BPCR) Stock Price Passes Below 200 Day Moving Average – Should You Sell?

BioPharma Credit (LON:BPCRGet Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 0.88 ($0.01) and traded as low as GBX 0.87 ($0.01). BioPharma Credit shares last traded at GBX 0.88 ($0.01), with a volume of 331,659 shares changing hands.

BioPharma Credit Stock Performance

The firm’s 50 day simple moving average is GBX 0.87 and its 200-day simple moving average is GBX 0.88. The company has a market capitalization of £10.54 million, a price-to-earnings ratio of 10.98 and a beta of 0.22.

BioPharma Credit Increases Dividend

The company also recently announced a dividend, which was paid on Tuesday, October 29th. Shareholders of record on Thursday, September 26th were paid a dividend of $0.04 per share. This is an increase from BioPharma Credit’s previous dividend of $0.02. This represents a yield of 4.26%. The ex-dividend date of this dividend was Thursday, September 26th. BioPharma Credit’s payout ratio is 8,750.00%.

BioPharma Credit Company Profile

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.